IL122655A0 - Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-N-[[2-methoxy-5-(1-methylethyl)phenyl]methyl] - Google Patents

Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-N-[[2-methoxy-5-(1-methylethyl)phenyl]methyl]

Info

Publication number
IL122655A0
IL122655A0 IL12265596A IL12265596A IL122655A0 IL 122655 A0 IL122655 A0 IL 122655A0 IL 12265596 A IL12265596 A IL 12265596A IL 12265596 A IL12265596 A IL 12265596A IL 122655 A0 IL122655 A0 IL 122655A0
Authority
IL
Israel
Prior art keywords
octan
diphenylmethyl
azabicyclo
methylethyl
methoxy
Prior art date
Application number
IL12265596A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL122655A0 publication Critical patent/IL122655A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
IL12265596A 1995-07-17 1996-07-04 Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-N-[[2-methoxy-5-(1-methylethyl)phenyl]methyl] IL122655A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US119195P 1995-07-17 1995-07-17
PCT/IB1996/000648 WO1997003984A1 (en) 1995-07-17 1996-07-04 Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-n-[[2-methoxy-5-(1-methylethyl)phenyl]methyl]

Publications (1)

Publication Number Publication Date
IL122655A0 true IL122655A0 (en) 1998-08-16

Family

ID=21694832

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12265596A IL122655A0 (en) 1995-07-17 1996-07-04 Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-N-[[2-methoxy-5-(1-methylethyl)phenyl]methyl]

Country Status (26)

Country Link
US (1) US6008357A (es)
EP (1) EP0840735B1 (es)
JP (1) JP3043074B2 (es)
KR (1) KR100276989B1 (es)
CN (1) CN1068598C (es)
AR (1) AR002772A1 (es)
AT (1) ATE250600T1 (es)
AU (1) AU697553B2 (es)
CA (1) CA2227194C (es)
CO (1) CO4480720A1 (es)
CZ (1) CZ15098A3 (es)
DE (1) DE69630123T2 (es)
DK (1) DK0840735T3 (es)
ES (1) ES2205039T3 (es)
HK (1) HK1010195A1 (es)
HU (1) HUP9900238A3 (es)
IL (1) IL122655A0 (es)
MY (1) MY115734A (es)
NO (1) NO980211L (es)
NZ (1) NZ310539A (es)
PE (1) PE8798A1 (es)
PL (1) PL184261B1 (es)
PT (1) PT840735E (es)
RU (1) RU2136681C1 (es)
WO (1) WO1997003984A1 (es)
ZA (1) ZA966026B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861526B2 (en) * 2002-10-16 2005-03-01 Pfizer Inc. Process for the preparation of (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine
AU2005210259A1 (en) * 2004-02-02 2005-08-18 Pfizer Products Inc. Process for preparation of 1-(2S,3S)-2-benzhydr yl-N-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine
JP2008519837A (ja) * 2004-11-10 2008-06-12 ベーリンガー インゲルハイム ケミカルズ インコーポレイテッド フェンタニル中間体の生成方法
CN102395557A (zh) * 2008-12-09 2012-03-28 佛罗里达大学研究基金会公司 激酶抑制剂化合物
US20160332962A1 (en) 2015-05-13 2016-11-17 Janssen Pharmaceutica Nv (s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
CN108341812A (zh) * 2017-01-23 2018-07-31 科贝源(北京)生物医药科技有限公司 一种含奎宁环化合物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX18467A (es) * 1988-11-23 1993-07-01 Pfizer Agentes terapeuticos de quinuclidinas
NO168529C (no) * 1989-09-15 1992-03-04 Chiron Lab As Fremgangsmaate for fremstilling av s-(-) og r-(+)-n-(quinuclidinyl-3)-amider.
DK0585328T3 (da) * 1991-05-22 2002-02-11 Pfizer Substituerede 3-aminoquinuclidiner
RU2103269C1 (ru) * 1991-05-31 1998-01-27 Пфайзер Инк. Производные хинуклидина или их фармацевтически приемлемые соли и фармацевтическая композиция
US5604241A (en) * 1992-10-21 1997-02-18 Pfizer Inc. Substituted benzylaminoquinuclidines as substance P antagonists

Also Published As

Publication number Publication date
PL324610A1 (en) 1998-06-08
US6008357A (en) 1999-12-28
CA2227194C (en) 2002-02-12
AU697553B2 (en) 1998-10-08
HUP9900238A2 (hu) 1999-05-28
CA2227194A1 (en) 1997-02-06
AU6134896A (en) 1997-02-18
RU2136681C1 (ru) 1999-09-10
CZ15098A3 (cs) 1999-02-17
AR002772A1 (es) 1998-04-29
CN1068598C (zh) 2001-07-18
EP0840735A1 (en) 1998-05-13
CN1190970A (zh) 1998-08-19
JP3043074B2 (ja) 2000-05-22
WO1997003984A1 (en) 1997-02-06
KR19990029058A (ko) 1999-04-15
HUP9900238A3 (en) 2001-08-28
DE69630123D1 (en) 2003-10-30
JPH10511102A (ja) 1998-10-27
NZ310539A (en) 1998-11-25
ES2205039T3 (es) 2004-05-01
PT840735E (pt) 2004-02-27
NO980211D0 (no) 1998-01-16
PL184261B1 (pl) 2002-09-30
MX9800538A (es) 1998-05-31
MY115734A (en) 2003-08-30
ATE250600T1 (de) 2003-10-15
DE69630123T2 (de) 2004-04-08
HK1010195A1 (en) 1999-06-17
DK0840735T3 (da) 2004-02-09
EP0840735B1 (en) 2003-09-24
PE8798A1 (es) 1998-03-02
CO4480720A1 (es) 1997-07-09
ZA966026B (en) 1998-01-16
KR100276989B1 (ko) 2001-01-15
NO980211L (no) 1998-03-16

Similar Documents

Publication Publication Date Title
FR2687055B1 (fr) Pinceau pour l'application de vernis a ongles, ou de produit similaire.
ITBO930097A0 (it) Apparecchio per l'equilibratura dinamica di un corpo rotante.
ZA968956B (en) Substituted 2,4-imidazolidinedione compounds as pharmaceutical active ingredients
FR2674300B3 (fr) Axe d'articulation, notamment pour un couvercle.
HU9700574D0 (en) Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical active agents
AU1642095A (en) 3,5-disubstituted tetrahydrofuran-2-ones
IL122987A0 (en) Novel 2,3-dioso-1, 2, 3, 4-tetrahydro-quinoxalinyl derivatives
AU699201B2 (en) Highly fluidized concrete composition
FI941776A0 (fi) Menetelmä 1,2,4-tiadiatsolien valmistamiseksi
HUP9900238A3 (en) Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-n-[[2-methoxy-5-(1-methylethyl)phenyl]methyl]
AU7480694A (en) 3-(benzofuran-7-yl)-6-haloalkyluracils
AU5624594A (en) Pyridyl-1,2,4-thiadiazoles as pest-control agents
HUP0001751A3 (en) A process for the preparation of 1,4,7,10-tetraazacyclododecane
HUP9800297A3 (en) Use of 3,4-diphenyl chromans for the manufacture of a vasodilatory pharmaceutical composition
EP0690053A3 (de) Verfahren zur Herstellung von 2,5-Dihydrofuran
AU2229597A (en) Model for the layer 1 iso-osi protocol intended to handle a set of common hardware resources
FI974002A (fi) Menetelmä ranitidiinihydrokloridi 1 muodon valmistamiseksi
ZA9610589B (en) Pharmaceutical compounds.
ZA974929B (en) New forms of organic salts of N'N-diacetylcystine.
EP0799185A4 (en) DIMERES 1,3,3- (TRISUBSTITUES) CYCLOHEXANE AND RELATED COMPOUNDS
AU1972097A (en) Process for the preparation of form 1 ranitidine hydrochloride
AU1325095A (en) Novel 3-(substituted methyl)-4-oxa-1-azabicyclo{3.2.0}heptan-7-one derivatives useful as antitumor agents
SG63714A1 (en) Process for the preparation of 5-(alkoxmethyl)-2, 3-pyridinedicarboximide compounds
EP0799181A4 (en) DIMERES 3.3- (DISUBSTITUTED) CYCLOHEXANE-1-CARBOXYLATE AND RELATED COMPOUNDS
FR2687068B1 (fr) Composition pour empreintes dentaires.